Predict your next investment

Corporation
bh-3.com

See what CB Insights has to offer

Investments

1

Funds

4

About BH3

BH3 is a real estate development firm that specializes in multifamily, residential condominium, and mixed-use properties in South Florida and New York City.

BH3 Headquarter Location

21500 Biscayne Boulevard Suite 302

Aventura, Florida, 33180,

United States

954-416-3140

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest BH3 News

BH3 Profiling as a Companion Diagnostic For Velcade

Nov 18, 2021

Award Information Branch: National Institutes of Health Contract: N43CO201000134 Award End Date (Contract End Date):N/A Small Business Information Abstract There is a clear need to better define patient-specific treatment strategies for the use of both standard and novel therapies for treating multiple myeloma. Eutropics is uniquely positioned to improve therapy efficacy for multiple myeloma by using a proprietary assay that provides a novel predictive biomarker, BH3 profiling. The assay uniquely assesses mitochondrial functionality in cancer cells. This technology is proven in preliminary studies to predict the patient responsiveness to combination multiple myeloma therapies that induce apoptosis. Velcade/Bortezomib is one component of these therapeutic protocols. In this phase I contract Eutropics wi ll continue to develop the BH3 profiling assay to a state that can be transferred to a CliA 88 approved partner lab. Biopsied multiple myeloma patient samples will be obtained from academic/clinical advisors at Dana Farber Cancer Institute and profiled in Eutropics labs in Boston, MA, using our proprietary assay. Patient outcome data wi ll be correlated to the assay results. Eutropics will apply for the phase 2 study that will deliver the final standard operating protocols that will provide the Velcade companion diagnostic test. Discussions with manufacturer of Velcade are underway for possible collaboration. * Information listed above is at the time of submission. *

BH3 Investments

1 Investments

BH3 has made 1 investments. Their latest investment was in Gridics as part of their Seed - II on November 11, 2017.

CBI Logo

BH3 Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/7/2017

Seed - II

Gridics

$1.6M

Yes

4

Date

11/7/2017

Round

Seed - II

Company

Gridics

Amount

$1.6M

New?

Yes

Co-Investors

Sources

4

BH3 Fund History

4 Fund Histories

BH3 has 4 funds, including BH3 Debt Opportunity Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

2/10/2020

BH3 Debt Opportunity Fund I

$36.88M

1

11/27/2019

KCP GRTNR Office International

$99M

10

11/27/2019

KCP GRTNR Office

$99M

10

1/25/2019

BH3-Indigo Holding

$99M

10

Closing Date

2/10/2020

11/27/2019

11/27/2019

1/25/2019

Fund

BH3 Debt Opportunity Fund I

KCP GRTNR Office International

KCP GRTNR Office

BH3-Indigo Holding

Fund Type

Status

Amount

$36.88M

$99M

$99M

$99M

Sources

1

10

10

10

BH3 Team

3 Team Members

BH3 has 3 team members, including current Founder, Chief Executive Officer, Gregory Freedman.

Name

Work History

Title

Status

Gregory Freedman

Founder, Chief Executive Officer

Current

Daniel Lebensohn

Founder, Chief Executive Officer

Current

Michelle Guber

Hines, and KKR

Chief Operating Officer

Current

Name

Gregory Freedman

Daniel Lebensohn

Michelle Guber

Work History

Hines, and KKR

Title

Founder, Chief Executive Officer

Founder, Chief Executive Officer

Chief Operating Officer

Status

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.